what is known already: Sexual dimorphism in adipose tissue distribution fully develops after puberty and modulates the risk for cardiometabolic disorders. However, the possibility that adipose tissue function exhibits sexual dimorphism as well as its distribution is unproved. study design, size, duration: Cross-sectional case-control study including 32 subjects. participants/materials, setting, methods: Sixteen subjects with weight excess (8 men and 8 women, including 4 overweight and 4 obese subjects in each group) and 16 normal weight healthy volunteers (8 men and 8 women) presenting with similar age were submitted to a 75-g oral glucose tolerance test (oGTT). We measured circulating concentrations of insulin, glucose, chemerin, lipocalin-2, omentin-1, leptin and adiponectin and calculated their areas under the oGTT curve (AUC).
Introduction
Adipose tissue plays a central role in the pathophysiology of obesitydependent diabetes mellitus-also known as diabesity-which is nowadays a leading cause of morbidity and mortality in westernized countries (Astrup and Finer, 2000) . The sexual dimorphism of adipose tissue distribution, resulting from the balance of androgens and estrogens, develops during puberty (Wells, 2007) . The predominantly abdominal and visceral deposition of adipose tissue typical of men, as opposed to the gluteal -femoral pattern of body fat deposition that characterizes premenopausal women, is of paramount importance because the association between adipose tissue accumulation and metabolic disorders such as diabesity is stronger for visceral (VAT) than for subcutaneous (SAT) adipose tissue excess (Matsuzawa, 2008; Ibrahim, 2010) .
VAT is a highly active metabolic organ that secretes a wide variety of bioactive molecules termed adipocytokines (Matsuzawa, 2008) . Excessive VAT deposition may result in dysregulated expression and secretion into the portal circulation of adipocyte-derived hormones and cytokines, linking abdominal adiposity, impaired insulin sensitivity and metabolic disturbances in peripheral tissues (Esteve et al., 2009) .
Besides the effect of sex hormones on fat deposition, androgens and estrogens might regulate directly the adipose tissue expression of certain adipokines that contain putative androgen and estrogen response elements in their gene promoter regions (Seth et al., 2002; Dhanasekaran et al., 2005) , or indirectly by means of posttranscriptional mechanisms (Trujillo and Scherer, 2006) , extending sexual dimorphism to adipose tissue function.
Our present knowledge about adipose tissue dysfunction in men and women is generated mostly from data obtained in the fasting state, even if humans spend a significant proportion of the day in the post-prandial state, and dietary triggers such as glucose are capable of inciting inflammatory responses in adipose tissue (Bolduc et al., 2010) . Adipose tissue, especially, VAT, is responsive to food intake and meal composition and, therefore, feeding and body fat content may modulate circulating adipokine concentrations (Bolduc et al., 2010; Unlütürk et al., 2010) .
In order to provide new insights on this important issue, we aimed to study the influence of sex and sex hormones on the response of circulating adipokines to an oral glucose challenge. With this goal in mind, we selected a panel of adipokines that play a pivotal role in the interplay between adiposity and glucose metabolism such as chemerin, lipocalin-2, omentin-1, leptin and adiponectin (Trujillo and Scherer, 2006; Esteve et al., 2009; Ernst and Sinal, 2010; MorenoNavarrete et al., 2010; Tan et al., 2010) .
Subjects and Methods

Subjects
We enrolled 8 men and 8 premenopausal women attending the clinical practices of the authors solely for the treatment of overweight (4 men and 4 women) or obesity (4 men and 4 women) and 16 normal weight healthy volunteers (8 men and 8 women). The groups were selected in order to be similar in terms of age. The women did not have signs or symptoms of androgen excess, menstrual dysfunction or history of infertility. Before enrollment, the participants had no history of obesity-associated comorbidities such as glucose tolerance abnormalities, hypertension, cardiovascular events or sleep apnea, and had not received treatment with oral contraceptives, antiandrogens, insulin sensitizers, statins, antihypertensives or any drugs that could influence body fat depots within the 6 previous months. Only one overweight woman smoked. All subjects provided informed written consent and the study was approved by the local ethics committee.
Study protocol
A clinical, anthropometric and physical evaluation that included body mass index (BMI), waist circumference and waist-to-hip ratio (WHR) was performed in all subjects. After 3 days on a 300-g per day carbohydrate diet and a 12-h overnight fasting, and during the follicular phase of the menstrual cycle in women, basal samples were obtained for the measurement of serum total testosterone (T) and estradiol (E 2 ), sex hormone-binding globulin (SHBG) and high-sensitivity C-reactive protein (hsCRP) concentrations. Then, a standard 75-g oral glucose tolerance test (oGTT) was performed, and samples were obtained at 0, 30, 60, 90 and 120 min for the measurement of serum insulin, plasma glucose and circulating levels of chemerin, lipocalin-2, omentin-1, adiponectin and leptin. Samples were immediately centrifuged, and serum was separated and frozen at 2308C until assayed. We followed the clinical recommendations of the American Diabetes Association to define the disorders of glucose tolerance (American Diabetes Association, 2012). We classified the subjects into two groups according to their BMI: normal weight (BMI , 25 kg/m 2 ) and weight excess (BMI ≥ 25 kg/m 2 , considering overweight and obesity as a whole) groups.
Assays
The technical characteristics of the assays employed for plasma glucose and serum hormone measurements have been described elsewhere . Free T and free E 2 levels were calculated from their total levels and SHBG concentration (Mazer, 2009) . The composite insulin sensitivity index was calculated from the glucose and insulin concentrations measured during the oGTT (Matsuda and DeFronzo, 1999) . The areas under the curve (AUC) of glucose, insulin and adipokines during the oGTT were determined according to the mathematical method described by Tai (1994) . hsCRP concentrations were measured by automated immunochemiluminescence (Immulite 2000 High-Sensitivity CRP, Diagnostic Products Corporation, Los Angeles, CA, USA) with a lower limit of detection of 0.95 mmol/l, and intra-and inter-assay coefficients of variation ,10%. Serum was assayed for chemerin, lipocalin-2, omentin-1, leptin and adiponectin using commercial ELISA kits (BioVendor Laboratorní medicina a.s., Brno, Czech Republic). The lower limits of detection and intra-and inter-assay coefficients of variation were 6.3 pmol/l, 6.1 and 7.6% for chemerin, 0.9 pmol/l, 7.7 and 9.7% for lipocalin-2, 16.4 pmol/l, 3.7 and 4.6% for omentin-1, 12.5 pmol/l, 5.9 and 5.6% for leptin and 0.9 nmol/l, 4.9 and 6.7% for adiponectin.
Statistical analysis
Results are expressed as mean + SD or counts (percentage) unless otherwise stated. Nominal variables were analyzed by x 2 or Fisher's exact test. The Kolmogorov-Smirnov statistic was applied to continuous variables. Logarithmic transformation ensured a normal distribution of variables as needed. We used univariate two-way general Sexual dimorphism in circulating adipokines linear models (GLMs) to evaluate differences in continuous variables between men and women and between normal weight and weight excess groups within a single analysis, while adjusting the level of significance to compensate for the multiple comparisons involved. Plasma glucose, serum insulin and serum adipokine levels were submitted to repeated-measures GLM introducing their concentrations during the oGTT as within-subjects effect and sex and weight group as between-subjects effects. We used Mauchly's test to measure sphericity and applied Greenhouse-Geisser epsilon adjustment as needed. The Greenhouse-Geisser correction introduces a correction factor (epsilon) that is based on the magnitude of the heterogeneity of the variances, which increases the critical F-value, thereby reducing the probability of type I errors. The relationships between continuous variables and the AUC of adipokines during oGTT were assessed by Pearson's and partial correlation analyses. Stepwise (probability for entry ≤0.05, probability for removal ≥0.10) multiple linear regression analyses adjusted for sex and BMI (these variables were manually entered in the model) were performed in order to identify the main determinants of the AUC in response to oral glucose of the different adipokines. These AUCs were used as dependent variables, whereas waist circumference or WHR (the one showing with a higher correlation coefficient was introduced as an independent variable in the model to avoid colinearity), hsCRP, free T, free E 2 , AUC of glucose and AUC of insulin were introduced as independent variables. We used SPSS Statistics 17.0 (SPSS Ibérica, Madrid, Spain) for analyses. P-values ,0.05 were considered statistically significant.
Results
Effects of sex and obesity on clinical and biochemical variables at baseline
These data are summarized in Table I . As expected from the study design, we did find no differences between men and women in 
Data are means + SD and counts (percentage) as appropriate. The effects of sex and weight excess on continuous variables were analyzed by a two-way GLM after applying logarithmic transformations as needed to ensure a normal distribution of the variables. Dichotomous variables were analyzed by x 2 or Fisher's tests as needed. hsCRP, high-sensitivity C-reactive protein; SHBG, sex hormone-binding globulin.
terms of age and BMI. Besides their higher total T and free T levels, men also had higher waist circumference and WHR compared with women who, in contrast, had higher levels of total E 2 , free E 2 and SHBG than men. Compared with normal weight individuals, subjects with weight excess had higher hsCRP concentrations and AUC of insulin, and lower SHBG levels and insulin sensitivity index. Other than the interaction found in free T levels-which were higher in women and lower in men with weight excess, compared with their normal weight counterparts-no interaction between sex and weight excess was found in any of these variables, meaning that the effects of sex were the same in lean subjects and in individuals with weight excess, and that the effects of weight excess were the same in men and in women. The frequency of disorders of glucose tolerance was similar among men and women, yet subjects with weight excess showed a higher frequency of impaired glucose tolerance compared with normal weight individuals. No subject had diabetes.
Effects of weight excess on fasting circulating adipokine concentrations and on the changes observed during the oGTT
In the fasting state, subjects with weight excess, irrespective of their sex, showed higher concentrations of chemerin and leptin, and lower levels of omentin-1 and adiponectin, compared with their normal weight counterparts (Table I) . BMI correlated positively with fasting chemerin (r ¼ 0.75, P , 0.001) and leptin (r ¼ 0.78, P , 0.001) concentrations, and negatively with fasting omentin-1 (r ¼ 20.57, P ¼ 0.001) levels. No statistically significant correlations were found between BMI and fasting adiponectin (r ¼ 20.30, P ¼ 0.092) or lipocalin-2 (r ¼ 0.28, P ¼ 0.126) concentrations. After adjusting for BMI, waist circumference showed a negative correlation with fasting adiponectin (r ¼ 20.41; P ¼ 0.024) and, interestingly, with leptin concentrations (r ¼ 20.56, P ¼ 0.001). Both men and women with weight excess showed higher glucose and insulin concentrations in all the measurements performed after the oral glucose load compared with their normal weight counterparts (F ¼ 7.9, P ¼ 0.009 and F ¼ 3.7, P ¼ 0.018, respectively, Fig. 1 ). Of all the adipokines studied here, only lipocalin-2 changed significantly during the oGTT, decreasing after oral glucose administration irrespective of sex and weight excess (F ¼ 5.3, P ¼ 0.004, Fig. 1, left panel) . No changes were observed in the concentrations of chemerin, omentin-1, leptin and adiponectin during the oGTT, yet subjects with weight excess had higher concentrations and AUC of chemerin and leptin, and lower omentin-1 and adiponectin levels and AUC, independently of sex (Figs 1 and 2, left panels).
When considering men and women as a whole, BMI showed strong positive correlations with the AUCs of chemerin and leptin and negative correlations with omentin-1 and adiponectin, but did not correlate with the AUC of lipocalin-2 (Table II) . Waist circumference showed positive correlations with AUC of chemerin, lipocalin-2 and leptin, and negative with AUC of omentin-1 and adiponectin (Table II) . After adjusting for the BMI, only the AUC of leptin and adiponectin maintained statistically significant correlations with waist circumference (Table II) .
Effects of sex and sex steroids on fasting circulating adipokine concentrations and on the changes observed during the oGTT Independently of being lean or having weight excess, women showed higher fasting circulating leptin and adiponectin concentrations than men, whereas sex had no effect on chemerin, lipocalin-2 nor on omentin-1 fasting concentrations (Table I ). In keeping with this effect of sex, baseline free T levels were negatively correlated with fasting leptin (r ¼ 20.39, P ¼ 0.030) and adiponectin (r ¼ 20.59, P , 0.001) concentrations, although no statistically significant correlations with free E 2 concentrations were found (r ¼ 0.22, P ¼ 0.218 for leptin and r ¼ 0.33, P ¼ 0.062 for adiponectin). Neither free T nor E 2 concentrations showed any statistically significant correlation with fasting chemerin, lipocalin-2 or omentin-1 levels.
During oGTT, sex had no effect either on the changes in plasma glucose or on serum insulin (F ¼ 1.6, P ¼ 0.201 and F ¼ 0.8, P ¼ 0.490, respectively; Fig. 1, middle panels) . Nevertheless, sex influenced leptin and adiponectin concentrations and AUC, which were higher in women compared with men irrespective of their normal or excessive weight (Figs 1 and 2 , middle panels). The AUC of leptin showed a negative correlation with free T (Table II) . The AUC of adiponectin negatively correlated with free T and positively with free E 2 (Table II) . No influence of sex or correlation with sex steroids was observed on other adipokines, when considering as a whole subject with normal or excessive weight (Table II) .
Interaction between sex and weight excess on fasting circulating adipokine concentrations and on the changes observed during the oGTT
The only statistically significant interaction between sex and weight excess on fasting levels (Table I) or on the concentrations reached during the oGTT (Figs 1 and 2 , right panels) was found for lipocalin-2 (F ¼ 2.9, P ¼ 0.048 for the interaction among changes in lipocalin-2 levels, weight subgroup and sex; Fig. 1 , right panels). While men with weight excess maintained higher lipocalin-2 concentrations compared with lean men throughout the oGTT, women with weight excess showed a significant decrease in these levels that, at the end of the oGTT, were lower than those of normal weight women (Fig. 1, right panel) . The same was observed for the AUC of lipocalin-2 (F ¼ 8.5, P ¼ 0.007 for the interaction between sex and weight subgroup; Fig. 2, right panel) .
Main determinants of the AUC of adipokine concentrations during the oGTT
We performed multiple regression analyses to identify the main determinants of AUC of adipokines among sex, BMI, waist circumference or WHR, hsCRP, free circulating concentrations of T and E 2 and AUCs of glucose and insulin (Fig. 3) . Higher BMI and hsCRP levels, and lower E 2 concentrations were associated with higher chemerin AUC, explaining 63% of the variability in its values (Fig. 3) . The multiple regression analysis for the AUC of lipocalin-2 only retained waist circumference as a major predictor, although the model did not reach statistical significance (Fig. 3) . Sex, BMI and free T explained 48% of the variability in the AUC of omentin-1 values (Fig. 3) . In the case of leptin AUC, both sex and BMI were their main determinants accounting for 73% of their variability (Fig. 3) . Finally, 62% of the changes observed in the AUC of adiponectin were attributable to BMI, free T, free E 2 and AUC of insulin (Fig. 3) .
Discussion
Our present results provide novel evidence suggesting sexual dimorphism in the pattern of secretion of several adipokines involved Figure 1 Circulating glucose, insulin and adipokines during the oGTT. Data are means + SEM. Black diamonds are men and women (n ¼ 16) with weight excess and white diamonds are men and women (n ¼ 16) with normal weight. Black and white circles are men (n ¼ 16) and black and white squares are women (n ¼ 16), including subjects with normal or excessive weight as a whole. White circles are normal weight men (n ¼ 8), black circles are men with weight excess (n ¼ 8), white squares are normal weight women (n ¼ 8) and black squares are women with weight excess (n ¼ 8). *P , 0.05 for the changes observed during the oGTT compared with baseline values, when considering all subjects as a whole.
† P , 0.05 for the differences between normal weight subjects and individuals with weight excess, independently of sex. ‡ P , 0.05 for the interaction between weight excess and sex. § P , 0.05 for the differences between men and women, independently of weight excess.
in glucose homeostasis. Sex is an important determinant of the risk of developing diabesity (Wild et al., 2004) . A key factor accounting for this influence is the sexual dimorphism of body fat distribution (Bjö rntorp, 1996). Sex steroids in both males and females have been closely related to the distribution of fat depots: men show an android pattern consisting in central and visceral deposition of body fat and the gynoid pattern of adiposity characteristic of premenopausal women switches to a more android distribution after menopause (Bjö rntorp, 1996). and white diamonds are men and women (n ¼ 16) with normal weight. Black and white circles are men (n ¼ 16) and black and white squares are women (n ¼ 16), including subjects with normal or excessive weight as a whole. White circles are normal weight men (n ¼ 8), black circles are men with weight excess (n ¼ 8), white squares are normal weight women (n ¼ 8) and black squares are women with weight excess (n ¼ 8). † P , 0.05 for the difference between normal weight and subjects with weight excess, independently of sex. ‡ P , 0.05 for the interaction between sex and weight excess. § P , 0.05 for the difference between men and women, independently of weight excess. But sexual dimorphism may not be limited to body fat distribution but may also involve adipose tissue function (Sparks et al., 2009) . Metabolically, women are more flexible than men-metabolic flexibility is defined as the ability to transition between fat oxidation (fasting state) and glucose oxidation (fed state)-showing an increase in insulin-stimulated glucose oxidation. Compared with men, women have greater capacity for insulin suppression of non-esterified fatty acids and present with an anti-inflammatory pattern of gene expression in adipose tissue macrophages (Sparks et al., 2009) . Moreover, the pattern of gene expression in VAT and SAT of several of the adipokines here studied, including chemerin, lipocalin-2 and omentin-1, is clearly different in severely obese men and women (Martínez-García et al., 2013) . Our present results indicate sex-dependent differences in the circulating levels of several adipokines involved in glucose metabolism, and a role for sex hormones in these differences, further supporting sexual dimorphism in adipose tissue function.
First, serum lipocalin-2 concentrations after a glucose load were clearly different in men and women, with obesity playing an influence in these differences, because abdominal adiposity apparently was its main determinant. Lipocalin-2, a secretory glycoprotein implicated in innate immunity against bacterial infections, is a circulating marker of obesity acting as an adipocyte-derived mediator of insulin resistance (Esteve et al., 2009) . The enhanced conversion of inactive cortisone into active cortisol in VAT from overweight subjects might favor lipocalin-2 expression and secretion in these subjects because the gene encoding lipocalin-2 is strongly induced by dexametasone in white adipose tissue (Yan et al., 2007) .
In our study, lipocalin-2 concentrations decreased during the oGTT when considering all the subjects as a whole, but whereas men with weight excess maintained higher values than their normal weight counterparts throughout the entire oGTT, women with weight excess showed a marked decline in circulating lipocalin-2 levels that were even lower than those of lean women at the end of the oGTT. The decrease in serum lipocalin-2 concentrations is a relatively surprising finding because hyperglycemia may enhance the expression of lipocalin-2 in adipocytes (Yan et al., 2007) . However, circulating Figure 3 Main determinants of the AUC of the oGTT of circulating adipokines when considering all subjects (men and women presenting with normal or excessive weight) as a whole. Multiple regression analysis adjusted for sex and BMI, using a stepwise method for the introduction of independent variables, was implemented to identify the main determinants of the AUC of adipokines among waist circumference or WHR (in order to avoid colinearity only the one with a higher correlation coefficient was introduced as an independent variable), hsCRP, free T, free E 2 , AUC of glucose and AUC of insulin. Sex was coded as a dummy variable (men ¼ 1, women ¼ 0). The diamonds correspond to the standardized regression coefficients (b, or the change in terms of standard deviations in the dependent variable that results from a change of 1 SD in the independent variable) and the error bars indicate the 95% CI of b. R 2 ¼ adjusted coefficient of determination.
Sexual dimorphism in circulating adipokines lipocalin-2 concentrations may derive from sources other than adipose tissue such as the liver, and lipocalin-2 secretion may be even downregulated in liver by hyperglycemia (Lin et al., 2001) . Previous studies reported that lipocalin-2 levels are higher in men compared with women (Wang et al., 2007) , and we may hypothesize that a more potent suppressive effect of oral glucose administration might be needed in the former, explaining why the men with weight excess in our study did not show the marked decrease observed in overweight and obese women. But also, these sex-specific findings may be an estrogen-mediated difference in the regulation of lipocalin-2 synthesis and secretion as gene expression profiles of estrogen responsive cells isolated from normal breast tissue have identified the gene encoding lipocalin-2 as a potential estrogen target (Seth et al., 2002) . Secondly, in our present study, both adiponectin and leptin concentrations were different in men and women irrespective of having normal or excessive weight-weight excess also influenced adiponectin and leptin concentrations in men and women-even when these levels did not change in response to an oral glucose challenge. Both adiponectin and leptin levels were higher in women compared with men; weight excess resulted in lower adiponectin concentrations and in higher leptin levels, irrespective of sex. Moreover, adiponectin concentrations correlated negatively with BMI and free T and correlated positively with free E 2 .
The existence of sexual dimorphism in adiponectin and leptin metabolism is supported by previous studies. After sexual maturation, adiponectin levels in female mice are twice than those found in males (Trujillo and Scherer, 2006) . In addition, T selectively reduces the release of the high-molecular-weight form of adiponectin (Trujillo and Scherer, 2006) . Furthermore, hyperandrogenic women present with hypoadiponectinemia irrespective of weight excess (Toulis et al., 2009) and the amelioration of androgen excess by using an antiandrogenic contraceptive pill increases serum adiponectin levels in obese patients with androgen excess (Luque-Ramírez et al., 2008) , further suggesting a role for androgens in the regulation of adiponectin levels. Regarding the effect of weight excess, and as found in our men and women, most studies conducted to date show a decrease in serum adiponectin levels in insulin-resistant conditions such as obesity and diabetes (Trujillo and Scherer, 2006; Esteve et al., 2009) . Moreover, adiponectin favors insulin action in adipose tissue (Trujillo and Scherer, 2006; Esteve et al., 2009) and correlates with metabolic flexibility, suggesting a role of adiponectin in the sexual dimorphism of fat metabolism (Sparks et al., 2009) .
Our present finding of higher leptin levels in women compared with men, and the inclusion of sex and BMI as the main determinants of serum leptin levels, is in agreement with previous reports that showed higher leptin levels in women than in men at any percent body fat or fat mass (Saad et al., 1997) . This sex difference was not apparently explained by sex hormones or body fat distribution, since these increased leptin levels were also found in women after menopause (Saad et al., 1997) . In conceptual agreement, the smaller waist circumference of women compared with men, which was present in both lean subjects and individuals with weight excess in our present series, may explain the negative correlation among abdominal adiposity and leptin concentrations observed in our study. On the contrary, global adiposity appears to determine serum leptin concentrations (Saad et al., 1997) , and this also explains the increased leptin concentrations of the subjects with weight excess studied here when compared with their normal weight counterparts. Of note, sex hormones were not among the main determinants of serum leptin concentrations in our series.
We were not able to confirm any significant change in adiponectin concentrations after oral glucose administration, in disagreement with previous reports that demonstrated a decrease in serum high-molecular-weight adiponectin levels after an oral glucose load in subjects with normal glucose tolerance but not those with impaired glucose tolerance (Ozeki et al., 2009) . The fact that we measured total adiponectin instead of its high-molecular-weight form, together with the high frequency of impaired glucose tolerance in our series, may explain these discrepancies. Finally, we did find no significant changes in leptin levels during oGTT in accordance with previous studies (Saad et al., 1997) .
Thirdly, sex hormones appear to influence also chemerin and omentin-1 concentrations, although our data do not support sexual dimorphism in the circulating levels of these adipokines. Chemerin is a chemoattractant hepatoadipokine that induces insulin resistance in the skeletal muscle of mouse models in vivo by reducing insulinstimulated Akt1 phosphorylation and AMPK-a activation (Becker et al., 2010) though, intriguingly, it enhances insulin-dependent glucose uptake in adipocytes in vitro (Takahashi et al., 2008) , suppresses gluconeogenesis in the liver (Takahashi et al., 2011) and positively regulates glucose-dependent insulin secretion (Takahashi et al., 2011) . In humans, chemerin seems to be closely linked up to obesity-related glucose homeostasis, especially, in individuals with impaired glucose tolerance, reflecting adipose tissue dysfunction as an early pathogenic event in type 2 DM development (Tö njes et al., 2010). In accordance with previously published data (Ernst and Sinal, 2010) , we found a strong correlation between BMI and chemerin levels during the oGTT, and serum chemerin concentrations were increased in men and women with weight excess compared with their normal weight counterparts. Likewise, chemerin concentrations were also associated with the increasing hsCRP levels, independently of BMI, supporting its role as a modulator in the interplay between obesity and inflammation (Ernst and Sinal, 2010) . Furthermore, in our series, serum chemerin levels during the oGTT were negatively associated with free E 2 levels in multiple regression analysis, despite chemerin levels being similar in men and women. Even when this association might indicate that E 2 influences chemerin secretion, an alternative explanation may arise from the fact that chemerin suppresses basal and FSH-stimulated E 2 secretion in granulosa cells from the ovary by down-regulating aromatase expression (Wang et al., 2012) . A similar mechanism may be involved in the higher chemerin concentrations found in Japanese men compared with women (Takahashi et al., 2013) , although such a difference has not been confirmed in other populations (Ernst and Sinal, 2010) .
Omentin-1 is an insulin-sensitizing adipokine predominantly expressed in VAT (Martínez-García et al., 2013) that enhances insulinstimulated glucose uptake in human adipocytes and triggers Akt signaling (Tan et al., 2010) . As previously described by others (de Souza Batista et al., 2007; Tan et al., 2010) , in our series, omentin-1 levels correlated negatively with BMI and abdominal adiposity and omentin-1 concentrations were decreased in men and women with weight excess compared with their normal weight counterparts. And even though we have not been able to confirm the finding of increased plasma omentin-1 levels in women compared with men (de Souza Batista et al., 2007) , our results indicate a role for sex hormones in the regulation of this adipokine, because circulating omentin-1 levels were negatively associated with free T concentrations. In agreement, in women with androgen excess increased free T levels are associated with decreased circulating omentin-1 concentrations (Choi et al., 2011) , and the promoter region of the gene encoding omentin-1 contains putative androgen response elements (Martínez-García et al., 2013) . Finally, as happened with other adipokines, we did not find any significant change in circulating omentin-1 levels during the oGTT in conformity with previous studies (Wurm et al., 2007) .
Our study, however, was not free of limitations. We included a relatively small sample size and, hence, we might have been underpowered to detect small differences arising from sex and/or weight excess in the circulating levels of some of these adipokines. Also, because this was a cross-sectional study, we cannot infer causality to the associations between the changes in circulating adipokine concentrations and the variables studied here. Even if our present data do not support a major impact of the acute ingestion of oral glucose on circulating adipokine concentrations, oral glucose is a very potent stimulus of insulin release that may uncover defects in insulin secretion and disorders in glucose tolerance in persons presenting with normal fasting plasma glucose and HbA 1c concentrations (Byrne et al., 1996) . Therefore, the study of adipokine concentrations after the ingestion of oral glucose had a priori the potential of providing a more complete picture of the influence of sex and weight excess than the study of fasting levels alone. Moreover, our present results cannot be extrapolated to the ingestion of lipids or proteins, or to a more physiological situation such as the ingestion of a standard meal.
In summary, our present results suggest sexual dimorphism in circulating levels of several adipokines involved in glucose metabolism and an influence of sex hormones in the regulation of adipose tissue function that should be considered when studying the link between glucose tolerance and adiposity.
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